These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9467135)

  • 1. Diagnosis and management algorithm of acute onset of central diabetes insipidus in critically ill children.
    Lugo N; Silver P; Nimkoff L; Caronia C; Sagy M
    J Pediatr Endocrinol Metab; 1997; 10(6):633-9. PubMed ID: 9467135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of vasopressin in comatose children with neurogenic diabetes insipidus.
    Lee YJ; Shen EY; Huang FY; Kao HA; Shyur SD
    J Pediatr Endocrinol Metab; 1995; 8(4):257-62. PubMed ID: 8821902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous vasopressin replacement in diabetes insipidus.
    Ralston C; Butt W
    Arch Dis Child; 1990 Aug; 65(8):896-7. PubMed ID: 2400231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous vasopressin infusion during chemotherapy in patients with diabetes insipidus.
    Bryant WP; O'Marcaigh AS; Ledger GA; Zimmerman D
    Cancer; 1994 Nov; 74(9):2589-92. PubMed ID: 7923015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the young child with postoperative central diabetes insipidus.
    McDonald JA; Martha PM; Kerrigan J; Clarke WL; Rogol AD; Blizzard RM
    Am J Dis Child; 1989 Feb; 143(2):201-4. PubMed ID: 2916492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient diabetes insipidus in a newborn infant.
    Fenton LJ; Kleinman LI
    J Pediatr; 1974 Jul; 85(1):79-81. PubMed ID: 4212478
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient Diabetes Insipidus After Discontinuation of Vasopressin in Neurological Intensive Care Unit Patients: Case Series and Literature Review.
    Bohl MA; Forseth J; Nakaji P
    World Neurosurg; 2017 Jan; 97():479-488. PubMed ID: 27742514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of diabetes insipidus in children.
    Wise-Faberowski L; Soriano SG; Ferrari L; McManus ML; Wolfsdorf JI; Majzoub J; Scott RM; Truog R; Rockoff MA
    J Neurosurg Anesthesiol; 2004 Jul; 16(3):220-5. PubMed ID: 15211159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative management of diabetes insipidus in children [corrected].
    Wise-Faberowski L; Soriano SG; Ferrari L; McManus ML; Wolfsdorf JI; Majzoub J; Scott RM; Truog R; Rockoff MA
    J Neurosurg Anesthesiol; 2004 Jan; 16(1):14-9. PubMed ID: 14676564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery.
    Katz K; Lawler J; Wax J; O'Connor R; Nadkarni V
    Resuscitation; 2000 Sep; 47(1):33-40. PubMed ID: 11004379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy.
    Vokes TJ; Gaskill MB; Robertson GL
    Ann Intern Med; 1988 Feb; 108(2):190-5. PubMed ID: 3341651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute postoperative diabetes insipidus treated with aqueous pitressin and patient weighing system].
    Kubota T; Uno E; Ito H; Yoshida K; Yamamoto S
    Neurol Med Chir (Tokyo); 1982 Nov; 22(11):943-8. PubMed ID: 6186936
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient diabetes insipidus after discontinuation of therapeutic vasopressin.
    Kristeller JL; Sterns RH
    Pharmacotherapy; 2004 Apr; 24(4):541-5. PubMed ID: 15098812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vasopressin (Pitressin) administration on sodium, potassium and urea excretion in rats with and without diabetes insipidus (DI), with a note on the excretion of vasopressin in the DI rat.
    Laycock JF; Williams PG
    J Endocrinol; 1973 Jan; 56(1):111-20. PubMed ID: 4683404
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of urine specific gravity in detecting diabetes insipidus in a patient with uncontrolled diabetes mellitus: urine specific gravity in differential diagnosis.
    Akarsu E; Buyukhatipoglu H; Aktaran S; Geyik R
    J Gen Intern Med; 2006 Nov; 21(11):C1-2. PubMed ID: 17026722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
    Aronson AS; Andersson KE; Bergstrand CG; Mulder JL
    Acta Paediatr Scand; 1973 Mar; 62(2):133-40. PubMed ID: 4691456
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of vasopressin (Pitressin) administration and dehydration on the concentration of solutes in renal fluids of rats with and without hereditary hypothalamic diabetes insipidus.
    Lee J; Williams PG
    J Physiol; 1972 Feb; 220(3):729-43. PubMed ID: 5016043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes insipidus caused by craniofacial trauma.
    Griffin JM; Hartley JH; Crow RW; Schatten WE
    J Trauma; 1976 Dec; 16(12):979-84. PubMed ID: 1003587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.